European Lithium Nears Critical Metals Merger: October Vote Hinges on Cash-or-Shares Choice

European Lithium shares rise 2.9% as scheme booklet for Critical Metals takeover is mailed; independent expert calls share scheme not fair but reasonable.

The clock is now ticking on European Lithium's absorption into Critical Metals Corp. With the scheme booklet dated 15 September and due to reach shareholders electronically and by post around 22 September — complete with proxy instructions — the long-flagged takeover by the Nasdaq-listed resources group has entered its decisive phase.

The market read the mailout as a tangible step toward completion. Shares changed hands pre-market at EUR 0.2345, up 2.9% on the prior close of EUR 0.2280, extending a run that has seen the stock add 12% over seven days and 16% across a month.

A Split Verdict From the Independent Expert

At the heart of the documentation lies a nuanced assessment. The independent expert rates the share scheme as not fair, yet reasonable and in the best interests of shareholders; the options scheme, by contrast, passes muster on both counts. What looks contradictory at first glance is better read as a sober judgment: the exchange value may not be ideal on pure valuation grounds, but the strategic logic of the combination holds up.

The independent board committee has duly recommended that investors vote in favour, including an opt-in mechanism allowing eligible holders to take cash instead of new Critical Metals stock. How many shareholders exercise that cash election will help determine how much of the combined company the remaining European Lithium holders keep. Under the original plan, existing shareholders were to hold roughly 41% of the merged group's outstanding common stock after completion.

The Variable Swap Ratio: A Moving Target

The terms themselves carry a wrinkle introduced in August that arguably represents the transaction's chief risk factor. Gone is the fixed exchange ratio of 0.035 new Critical Metals shares per European Lithium share. In its place stands a variable ratio tied to the volume-weighted average price of Critical Metals stock on the Nasdaq over 20 trading days, ending two days before the scheme vote.

The upshot: the value European Lithium shareholders ultimately receive will not be known until just before the ballot, and it depends on the price trajectory of a dollar-denominated security listed elsewhere. The formula shields both sides from swings in the other's stock during the waiting period, but it strips European Lithium holders of the certainty a fixed ratio would have provided.

Timeline: From Booklet to November Completion

Assuming the schedule holds, the booklet's distribution — now registered with Australian regulator ASIC — precedes the general meeting and scheme meetings on 22 October in West Leederville, Western Australia. Should shareholders and option holders approve and the court grant final sign-off, the schemes could be implemented in November.

That would see European Lithium folded entirely into Critical Metals, handing the acquirer full control of the Tanbreez rare earths project in Greenland — a deal originally valued at around USD 835 million in May. For shareholders choosing stock over cash, it amounts to a wager on how the combined entity is valued on the Nasdaq.

Valuation Gap and Vote Risk

The expert's refusal to label the share scheme "fair" is no minor footnote. It points to a gap between what shareholders might theoretically require and what the deal actually offers — ammunition for critics when the vote arrives in October. Completion also remains conditional on security holder approval, court sanction, and the satisfaction or waiver of remaining conditions.

Should the ballot fail or the court process stall, setbacks loom. With annualised 30-day volatility running at 78%, the shares could react sharply to negative news. The stock also sits 23% below its 52-week high of EUR 0.3055 touched in early June, suggesting some takeover optimism is already baked in — and with it, room for disappointment.

What Comes Next

As long as the roadmap holds — booklet this month, approval at the 22 October meeting, completion in November — the market looks set to keep trading the stock as a takeover candidate with a clear path forward, a view echoed by its 159% gain year-to-date. A rejection at the ballot, or fresh obstacles in court, would likely see that embedded premium erode quickly.

The next hard catalyst is firmly dated: the general and scheme meetings on 22 October 2026 in West Leederville. Until then, shareholders face one overriding question — whether they ultimately prefer cash in hand or a stake in the merged company.